Recently, FLOT1 was reported to be elevated in several types of cancer, including non-small cell lung cancer, breast cancer and hepatocellular carcinoma, and played important roles in development and progression of cancer [20–22]. This evidence concerns the gene FLOT1 and hepatocellular carcinoma.